Cargando…

‘Less is more’ in the Chinese context

Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness...

Descripción completa

Detalles Bibliográficos
Autor principal: XU, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858509/
https://www.ncbi.nlm.nih.gov/pubmed/27199529
http://dx.doi.org/10.11919/j.issn.1002-0829.215106
_version_ 1782430811705835520
author XU, Yifeng
author_facet XU, Yifeng
author_sort XU, Yifeng
collection PubMed
description Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness of medications, the dominant role of the doctor in doctor-patient negotiations about treatment, the practice of polypharmacy in Traditional Chinese Medicine (TCM), the profit-driven nature of medical institutions and individuals, the infiltration of pharmaceutical marketing, and a critical lack of relevant research. This commentary considers the cultural factors that need to be addressed when trying to reduce polypharmacy in psychiatry in China.
format Online
Article
Text
id pubmed-4858509
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Shanghai Municipal Bureau of Publishing
record_format MEDLINE/PubMed
spelling pubmed-48585092016-05-19 ‘Less is more’ in the Chinese context XU, Yifeng Shanghai Arch Psychiatry Decreasing Antipsychotic Polypharmacy Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness of medications, the dominant role of the doctor in doctor-patient negotiations about treatment, the practice of polypharmacy in Traditional Chinese Medicine (TCM), the profit-driven nature of medical institutions and individuals, the infiltration of pharmaceutical marketing, and a critical lack of relevant research. This commentary considers the cultural factors that need to be addressed when trying to reduce polypharmacy in psychiatry in China. Shanghai Municipal Bureau of Publishing 2015-12-25 /pmc/articles/PMC4858509/ /pubmed/27199529 http://dx.doi.org/10.11919/j.issn.1002-0829.215106 Text en Copyright © 2015 by Shanghai Municipal Bureau of Publishing http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Decreasing Antipsychotic Polypharmacy
XU, Yifeng
‘Less is more’ in the Chinese context
title ‘Less is more’ in the Chinese context
title_full ‘Less is more’ in the Chinese context
title_fullStr ‘Less is more’ in the Chinese context
title_full_unstemmed ‘Less is more’ in the Chinese context
title_short ‘Less is more’ in the Chinese context
title_sort ‘less is more’ in the chinese context
topic Decreasing Antipsychotic Polypharmacy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858509/
https://www.ncbi.nlm.nih.gov/pubmed/27199529
http://dx.doi.org/10.11919/j.issn.1002-0829.215106
work_keys_str_mv AT xuyifeng lessismoreinthechinesecontext